netFormulary
 Report : A-Z CDF items in Formulary 19/06/2018 05:50:17
[Back]
 
Section Status CDF Name
08.03.04.02 Formulary Cancer Drugs Fund Abiraterone 
08.01.05 Formulary Cancer Drugs Fund Aflibercept Zaltrap
08.01.05 Formulary Cancer Drugs Fund Atezolizumab 
08.01.01 Formulary Cancer Drugs Fund Bendamustine 
08.01.05 Formulary Cancer Drugs Fund Bevacizumab Avastin
08.01.05 Formulary Cancer Drugs Fund Bortezomib 
08.01.05 Formulary Cancer Drugs Fund Bosutinib 
08.01.05 Formulary Cancer Drugs Fund Brentuximab vedotin Adcetris
08.01.05 Formulary Cancer Drugs Fund Cabazitaxel 
08.01.05 Non Formulary Cancer Drugs Fund Cabozantinib Cometriq
08.01.05 Formulary Cancer Drugs Fund Cetuximab 
08.01.03 Non Formulary Cancer Drugs Fund Clofarabine Evoltra
08.01.05 Formulary Cancer Drugs Fund Crizotinib 
08.01.05 Formulary Cancer Drugs Fund Dabrafenib Tafinlar
08.01.05 Formulary Cancer Drugs Fund Eribulin Halaven
08.01.05 Formulary Cancer Drugs Fund Ibrutinib Imbruvica
08.01.05 Formulary Cancer Drugs Fund Idelalisib 
08.02.04 Formulary Cancer Drugs Fund Lenalidomide 
08.01.03 Non Formulary Cancer Drugs Fund Nelarabine Atriance
08.01.05 Non Formulary Cancer Drugs Fund Panitumumab Vectibix
08.01.03 Formulary Cancer Drugs Fund Pemetrexed 
08.01.05 Formulary Cancer Drugs Fund Pertuzumab Perjeta
08.02.04 Formulary Cancer Drugs Fund Pomalidomide Imnovid
08.01.05 Formulary Cancer Drugs Fund Ponatinib Iclusig
08.01.05 Formulary Cancer Drugs Fund Regorafenib Stivarga
08.01.05 Formulary Cancer Drugs Fund Ruxolitinib 
08.01.05 Formulary Cancer Drugs Fund Sorafenib 
08.01.05 Formulary Cancer Drugs Fund Sunitinib 
08.01.05 Formulary Cancer Drugs Fund Trastuzumab emtansine Kadcyla
08.01.05 Non Formulary Cancer Drugs Fund Vandetanib Caprelsa
08.01.05 Non Formulary Cancer Drugs Fund Vismodegib Erivedge
Sunderland Joint Formulary